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Abstract
Objective The aim of the study was to determine whether the
introduction of the Enhanced Recovery after Surgery (ERAS)
protocol in laparoscopic total mesorectal excision (TME) for
rectal cancer offers additional advantages concerning postop-
erative hospital stay compared to laparoscopy and conventional
care.
Methods A consecutive series of patients that underwent a
laparoscopic TME for rectal cancer in a single institution
between January 2004 and July 2009 were retrospectively
included in this study. The ERAS protocol was introduced in
this cohort in January 2007. The study cohort was divided in a
conventional care group and an ERAS group. Both groups
were compared for primary and secondary outcomemeasures.
The primary outcome measure was postoperative length of
hospital stay.
Results Seventy-six patients were included: 43 in the ERAS
group and 33 in the conventional care (control) group. Median
hospital stay was 7 days (range 2–83 days) in the ERAS group
and 10 days (range 4–74 days) in the control group (p00.04).
Return of bowel function occurred on days 2 and 3 respectively
(p<0.001). There were no significant differences between both
groups concerning postoperative complications, readmission
rate and reoperations. Thirty-day mortality was absent in both
groups.
Conclusion These results suggest that the introduction of
the ERAS protocol in laparoscopic TME leads to a further
reduction in length of hospital stay.
Keywords ERAS . Laparoscopic surgery . Rectal cancer .
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Introduction
Laparoscopic surgery has several advantages over open sur-
gery. These advantages are less postoperative pain, quicker
return of bowel function, less postoperative morbidity and
shorter duration of hospital stay [1, 2].
Laparoscopic TME is relatively new, but has proven to be
a reliable and safe alternative for the conventional open
TME. It seems that laparoscopic TME is the treatment of
choice when there are no (relative) contraindications for
laparoscopic surgery [3, 4].
The Enhanced Recovery after Surgery (ERAS) protocol,
also known as ‘fast-track’ surgery, was originally developed
to enhance postoperative recovery and thereby shorten hos-
pital stay for patients undergoing elective colonic resection
[2]. The first results of randomised trials are very promising,
reporting postoperative hospital stay of 2–4 days in favour
of laparoscopic resections [5–7].
The key pathogenic factor in postoperative morbidity,
when failures of surgical and anaesthetic techniques have
been excluded, is the surgical stress response with subse-
quent increased demands on organ functions [8].
The body responds to surgical stress with profound
changes in neural, endocrine and metabolic systems in addi-
tion to alterations in organ functions. Postoperatively, this may
lead to complications such as myocardial infarction, delirium,
pulmonary dysfunction, thromboembolism and infectious
complications. Much effort was made to improve each of
these specific outcome variables by unimodal therapeutic
strategies [8]. The ERAS protocol, however, is a multimodal
approach to all of these ‘medical’ complications. By reducing
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stress and pain in patients undergoing colorectal resections
together with aggressive postoperative mobilisation and early
oral feeding, the body’s stress response and organ dysfunction
are reduced to a minimum, thus facilitating early recovery and
reducing postoperative morbidity and mortality [9].
With respect to postoperative recovery and the duration
of postoperative hospital stay, both laparoscopic surgery and
the ERAS protocol share the same objective. If both lapa-
roscopic TME and ERAS are combined, can additional
advantages be expected concerning postoperative recovery
and the duration of hospital stay?
In order to investigate this question, a consecutive series
of patients treated for rectal cancer were retrospectively
divided in two groups. One group consisted of patients
treated in the pre-ERAS era (the conventional care group),
and the other group formed the ERAS group. Both groups
were compared for length of postoperative hospital stay.
Patients and methods
All 124 patients diagnosed with rectal cancer in a single centre
between January 2004 and July 2009 were analysed. Eighty-
four patients underwent an elective laparoscopic TME. Eight
patients were excluded due to conversion to open surgery. The
remaining 76 patients were all included in this study.
The ERAS protocol for laparoscopic rectal surgery was
introduced in this hospital in January 2007. Therefore, all
patients operated between January 2007 and July 2009
formed the ERAS group (N043). The patients that under-
went a rectal resection between January 2004 and January
2007 were assigned as a control group (N033).
All data were retrospectively collected from patient charts.
Collected data included age, body mass index (BMI), smok-
ing, hypertension, diabetes mellitus, the American Society of
Anaesthesiologists’ (ASA) classification, the type of proce-
dure, operation time, estimated blood loss, tumour distance
from the anal verge, preoperative treatment, type of anasto-
mosis, creation of a temporarily diverting or permanent stoma,
return of bowel function after surgery, postoperative compli-
cations, readmission and reoperation rate, 30-day mortality
and the primary outcome: length of postoperative hospital stay
(LOS). In addition, pathologic tumour characteristics were
obtained.
Tumour distance in centimetres from the anal verge was
measured using a rigid sigmoid scope. Preoperative treat-
ment consisted either of a limited (5×5.0 Gy) or extended
(25×2.0 Gy) radiotherapy (RT) regimen or chemo radiation
(25×2.0 Gy + capecitabine). All patients underwent either a
laparoscopic low anterior resection (LAR) or a laparoscopic
abdominal perineal resection (APR) according to the TME
principle. In both groups the operations were performed by
the same three surgeons, who were all well-trained in
laparoscopic rectal surgery. The type of anastomosis was de-
fined as end-to-end, end-to-side or side-to-side anastomosis.
Patients either received a diverting loop ileostomy or, in the
case of APR, a permanent colostomy. Return of bowel function
was defined as the first reported stoma production. The post-
operative complications considered were bleeding, wound in-
fection, anastomotic leakage and intra-abdominal abscess.
Anastomotic leakage was defined as clinical signs of peritonitis
together with a visualized anastomotic defect on colonoscopy
or colonic enema radiography, with or without an intra-
abdominal abscess. Intra-abdominal abscesses were radio-
graphically detected pockets of fluid in a presacral cavity. The
length of hospital stay was defined as the number of postoper-
ative days in the hospital (day of surgery 0 day 0). Readmission
days were not added to this calculation. Readmissions and
reoperations within 30 days after surgery were scored as either
“yes” or “no”. Readmissions and reoperations more than
30 days after discharge were not evaluated. Tumour character-
istics comprising maximal tumour diameter on pathological
examination, tumour differentiation grade, TNM-
classification and radicality of the resection were obtained.
The pre-ERAS protocol
Patients were admitted the day before their operation. They
received 4 L of oral bowel preparation (Klean-prep® Norgine
B.V., Amsterdam, The Netherlands). A daily dose of 0.3 ml
Fraxiparine® was administered. Patients were allowed a nor-
mal diet until midnight.
In the operating room all patients received a urinary
catheter. Thirty minutes before the first incision, cefazoline
(1,000 mg) and metronidazole (500 mg) were given intra-
venously. Patients were operated under general anaesthesia.
Nasogastric tubes were routinely used. In general, one drain
was placed in the pelvis.
Postoperatively, oral intake was prohibited, and standard
intravenous fluid was set at 2–2.5 L/24 h. Patients received
4,000 mg of paracetamol (in four separate doses of 1,000 mg).
If necessary, diclofenac 150 mg in three doses of 50 mg and
morphine substitutes were also given. Nasogastric tubes,
drains and catheters were removed at the surgeon’s decision.
After removal of the nasogastric tube, patients were allowed
clear fluids. Discharge was arranged when the following
criteria were met: There are no remaining lines or catheters,
solid food is tolerated, there has been passage of stool, pain is
controlled using oral analgesics only and the patient is able to
restart basic daily activities and self-care, or function at the
preoperative level.
The ERAS protocol
Within the ERAS protocol perioperative care is standardised
to promote early mobilisation and resumption of a normal
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diet as first described by H. Kehlet [5, 8, 10]. All patients
that received the ‘multimodal approach’ (ERAS) agreed to
an informed consent preoperatively in an outpatient setting.
Patients were admitted the day before their operation to
receive an epidural catheter, placed at a low level (Th 9–
11, Table 1). Oral bowel preparation was omitted, but
patients received two enemas on the evening before surgery.
Daily doses of 0.3 ml Fraxiparine®, 4,000 mg of paraceta-
mol (in four separate doses of 1,000 mg) and 20 mg of
pantoprazole were administered, starting on the day before
surgery and continued until discharge. Patients were
allowed to maintain their normal diet until midnight. On
the day of surgery patients received another enema and two
packages of carbohydrate drinks. Patients were allowed oral
intake until 2 h before surgery.
In the operating room body temperature was maintained
using warm blankets. Target body temperature was ≥36°C.
All patients received a urinary catheter. Thirty minutes be-
fore the first incision, cefazoline (1,000 mg) and metronida-
zole (500 mg) were given intravenously. This was repeated
every 3.5 h. Five milligrams of dexamethasone and 4 mg of
ondansetrone were given preoperatively, and 1.5 mg halo-
peridol was given intraoperatively. Patients were ventilated
with 60 to 80% oxygen. Nasogastric tubes were not routine-
ly used. All analgesics were given through the epidural
catheter (levobupivacaine and sufentanil); the use of mor-
phine and diclofenac was avoided. In general, one intra-
abdominal drain was left behind.
Postoperatively, oral fluid intake was directly encouraged,
and intravenous fluid was restricted to 1 L per 24 h. In the
evening after surgery, a liquid diet was introduced. On the first
day after surgery, if oral fluid intake was sufficient, the intra-
venous catheter was disconnected. Magnesium oxide was
started, and the patient was allowed to restart a normal diet
at noon. Patients were stimulated to mobilise 2–3 h on the first
day.
On the second day after surgery, diclofenac was started in
a dose of 50 mg, three times daily, and the epidural catheter
was removed when pain was controlled properly (VAS<4/
10). The urinary catheter and unproductive abdominal
drains were removed, and patients were stimulated to fully
mobilise.
Discharge was arranged when the following criteria were
met: There are no remaining lines or catheters, solid food is
tolerated, there has been passage of stool, pain is controlled
using oral analgesics only and the patient is able to restart
basic daily activities and self-care, or function at the preoper-
ative level.
Statistical analysis
All collected data were entered in a database and analysed
using SPSS Statistics 17.0 for Windows. To determine signif-
icant differences between the ERAS and control groups, sta-
tistical analysis was performed using aχ2 test. A p-value <0.05
was considered statistically significant.
Continuous data are expressed as median (range) or as
mean (± SD) and were analysed using Mann–Whitney U test.
BMI was converted to a categorical variable, representing
Table 1 The ERAS protocol
The ERAS protocol
Day before surgery
- Normal diet until midnight
- Omission of oral bowel preparation
- 2 enemas in the evening
- An epidural catheter is placed at Th 9–11
- 0.3 ml Fraxiparine, 4000 mg paracetamol, 20 mg pantoprazole
(every day until discharge)
Day of surgery
- 1 enema in the morning
- 2 packages of carbohydrate drinks
- Oral intake until 2 h before surgery
- Target body temperature ≥36°C
- Urinary catheter is placed
- Dexamethasone (5 mg) and ondansetrone (4 mg) preoperatively
- Cefalozine (1000 mg) and metronidazole (500 mg) i.v. 30 min before
first incision
- Haloperidol (1.5 mg) intraoperatively
- Ventilation with 60–80% oxygen
- No nasogastric tubes
- All analgesics through the epidural catheter
- 1 intra-abdominal drain
- Oral fluid intake allowed and stimulated directly after surgery
- i.v. fluid restriction of 1 L per 24 h
- Liquid diet in the evening
Postoperative day 1
- Disconnection of the intravenous catheter
- Start magnesium oxide
- Restart normal diet at noon
- 2–3 h of mobilisation
Postoperative day 2
- Diclofenac 50 mg, 3 times daily
- Removal of epidural catheter (when pain is controlled properly)
- Removal of urinary catheter and intra-abdominal drain
- Full mobilisation
Discharge criteria
- No remaining lines or catheters
- Toleration of solid food
- There has been passage of stool
- Pain can be controlled using only oral analgesics
- Ability to conduct self-care or function at preoperative level
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certain risk groups. All categorical and dichotomous variables
were analyzed using χ2 test.
Primary outcome was length of hospital stay. To deter-
mine independent outcome predictors, all possible predic-
tors of the primary outcome were analysed in univariate and
multivariate regression models. In the multivariate analysis,
the backward regression method was used.
Results
In all patients in the ERAS group (43), an epidural catheter
was successfully placed. In two (4.7%) patients, the epidural
catheter had to be removed before day 2 because of dislo-
cation of the catheter. Twenty-one patients (49%) could be
disconnected from the intravenous catheter on day 1. In 37
(86.0%) patients the epidural catheter could be removed on
day 2.Twenty-one patients (49%) had their urinary catheter
removed on day 2. In total, 16 (37%) patients were managed
exactly according to the ERAS protocol.
Both groups were compared for demographics and
patient-related and tumour-related factors (Table 2). No
significant differences were found between both groups,
except for a history of diabetes. Nine patients in the ERAS
group and one in the conventional care group had diabetes.
Nearly all patients received preoperative treatment, consist-
ing of a short scheme (5×5.0 Gy) radiotherapy (RT), long
scheme (25×2.0 Gy) RT or chemo radiation (25×2.0 Gy +
capecitabine). Chemo radiation is a relatively new treatment
regimen for patients with locally advanced rectal cancer.
Therefore, this therapy was only observed in the ERAS
group. All patients underwent either laparoscopic low ante-
rior resection (LAR) or laparoscopic abdominal perineal
resection (APR). There was no difference between both
groups regarding the type of procedure.
Mean (total) operating time was 319±75 min in the
ERAS group and 356±91 min in the conventional care
group (p00.068). Median blood loss was 300 ml (0–2400)
and 400 ml (0–2400) respectively (p00.346). Operating
time tended to be longer for LAR, and mean blood loss
tended to be more for APR, but the differences did not reach
statistical significance (Table 3).
There is a significant difference in length of postoperative
hospital stay between both groups. The median postopera-
tive hospital stay was 10 (4–74) days for patients receiving
conventional care and 7 (2–83) days for patients that had
followed the ERAS protocol (p00.042). Furthermore, return
of bowel function occurred significantly earlier in the ERAS
group compared to the control group, with a median of 2 (1–7)
and 3 (1–14) days respectively (p<0.001).
No significant differences were found when both groups
were compared for postoperative complications, factors
delaying early discharge, and readmission and reoperation
rates within 30 days after surgery. In both groups 30-day
mortality was absent.
Haemorrhage occurred in one patient in the ERAS group
(p00.38); this patient needed reoperation. Four (9.3%) ERAS
patients developed a wound infection and two (6.1%) patients







Median (range) 64 (27–88) 66 (36–79) 0.156
Gender 0.726
Male 22 (66.7) 27 (62.8)
Female 11 (33.3) 16 (37.2)
BMI 0.456
<25 17 (58.6) 16 (41)
25–30 7 (24.1) 13 (33.3)
30–35 2 (6.9) 6 (15.4)
>35 3 (10.3) 4 (10.3)
Smoking (N063) 8 (24.2) 10 (23.3) 0.872
Hypertension 10 (30.3) 16 (38.1) 0.482
Diabetes 1 (3) 9 (21.4) 0.020
ASA classification 0.484
I 9 (27.3) 18 (41.9)
II 17 (51.5) 15 (34.9)
III 6 (18.2) 9 (20.9)
IV 1 (3) 1 (2.3)
UICC stage 0.155
0 1 (3.0) 1 (2.3)
I 12 (36.4) 11 (25.6)
II 13 (39.4) 11 (25.6)
III 7 (21.2) 20 (46.5)
Preoperative treatment <0.001
No preoperative treatment 4 (12.1) 1 (2.3)
RT short (5×5.0 Gy) 19 (57.6) 23 (53.5)
RT long (25×2.0 Gy) 10 (30.3) 3 (7)
Chemo radiation
(25×2.0 Gy + capecitabine)
0 16 (37.2)
Tumour distance from anal
verge (cm)
0.635
0–4 12 (36.4) 18 (41.9)
5–8 14 (42.4) 17 (39.5)
>8 7 (21.2) 8 (18.6)
Procedure 0.228
Lap. low anterior resection
(LAR)
25 (75.8) 27 (62.8)
Lap. abdominal perineal
resection (APR)
8 (24.2) 16 (37.2)
Values in parentheses are percentages unless indicated otherwise
BMI body mass index, ASA American Society of Anaesthesiology,
UICC Union for International Cancer Control, RT radiotherapy
*p-Value calculated by χ2 test
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in the conventional care group (p00.60). Anastomotic leakage
occurred in five (11.6%) and four (12.1%) patients respectively
(p00.95). Intra-abdominal abscesses were reported in seven
(16.3%) and three (9.1%) cases respectively (p00.36). Fur-
thermore, factors delaying early discharge were reported and
divided into gastro-intestinal factors (ileus, gastric paresis),
urological factors (bladder retention, prolonged requirement
of urinary catheter) and other factors (cardiovascular events,
pneumonia and urinary tract infections). No significant differ-
ences were found between both groups regarding these factors.
LOS was converted to a dichotomous variable, in order to
be able to perform logistic regression. The median hospital
stay of all patients was 8 days. Therefore, LOS of 1–7 days
and ≥8 days were used as cutoff points. All variables with p-
values less than 0.2 in the univariate analysis were entered
in the multivariate regression model. After univariate anal-
ysis, four possible predictors for length of hospital stay were
identified, including: age at time of operation, ASA classi-
fication, diabetes and the ERAS protocol (Table 4). Preop-
erative treatment was added to the multiple regression
analysis due to the significant differences between the
ERAS and control groups at baseline. After multivariate
analysis, both diabetes (OR 0.12, 95% CI 0.02–0.66, p0
0.015) and the ERAS protocol (OR 5.14, 95% CI 1.80–
14.65, p00.002) were independent predictors of the out-
come, a hospital stay of 1–7 days.
Discussion
In this study the authors found that since the introduction of
the ERAS protocol in laparoscopic TME for rectal cancer,
postoperative hospital stay was significantly reduced and
bowel function was restored earlier compared to laparoscopic
TME and conventional care. Although the results seem very
promising, the authors realize that this is a retrospective study
from which no definitive conclusions can be drawn.
Table 3 Results
Values in parentheses are
percentages unless indicated
otherwise









No ERAS (N033) ERAS (N043) p-Value
Operating time (min) (mean ± SD) 356±91 319±75 0.068*
LAR 368±96 323±76
APR 318±64 313±74
Total blood loss (ml) (median (range)) 400 (0–2400) 300 (0–2400) 0.346*
LAR 400 (0–2400) 250 (0–1700)
APR 600 (0–1100) 425 (0–2400)
Length of stay (days) 0.042*
Median (range) 10 (4–74) 7 (2–83)
Return of bowel function (days) <0.001*
Median (range) 3 (1–14) 2 (1–7)
Postoperative complications
Bleeding 0 1 (2.3) 0.378**
Wound infection 2 (6.1) 4 (9.3) 0.603**
Anastomotic leakage 4 (16.0) 5 (18.5) 0.947**
Intra-abdominal abscess 3 (9.1) 7 (16.3) 0.358**
Factors complicating early discharge 0.216**
No complications 12 (36.4) 19 (44.2)
Gastro-intestinal complications 10 (30.3) 5 (11.6)
Urological complications 6 (18.2) 13 (30.2)
Othera 5 (15.2) 6 (13.9)
Readmission (<30 days after surgery) 6 (18.2) 5 (11.6) 0.421**
Reoperation (<30 days after surgery) 5 (15.2) 7 (16.3) 0.894**
Mortality (<30 days after surgery) 0 0
Table 4 Univariate analysis investigating the effect on LOS (Univar-
iate results of variables added to the multivariate analysis)
Variable OR 95% CI p-Value
Age 1.04 0.99–1.08 0.055
ASA I 1 Reference 0.096
ASA II 0.39 0.13–1.13 0.081
ASA III 0.18 0.05–0.74 0.017
ERAS 3.52 1.35–9.20 0.010
Diabetes 0.24 0.48–1.23 0.087
Chemo radiation 1 Reference 0.235
Short (5×5.0 Gy) 0.31 0.09–1.05 0.060
Long (25×2.0 Gy) 0.28 0.06–1.32 0.109
OR odds ratio, CI confidence interval, ASA American Society of
Anaesthesiology
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To our knowledge no comparative studies on ERAS and
conventional care in laparoscopic rectal surgery have been
published so far. One recent study reported the results of
laparoscopic rectal resections combined with fast-track sur-
gery [11]. In that study (N037) the authors found a mean
hospital stay of 3 days (range 1–8). This is an excellent
result which has not been published before. However, there
were only 46% of the patients in the study that had a rectal
carcinoma, and all patients underwent a laparoscopic LAR.
In 19% a diverting loop ileostomy was performed. Mean
hospital stay in that group was 4 days (range 2–7). The 30-
day readmission rate was 8% and was not elevated by early
discharge. No anastomotic leakage occurred.
Similar results regarding LOS have been described for
laparoscopic colonic resections, but rectal resections have been
associated with median hospital stays of 12 or 13 days. The
introduction of the laparoscopic technique for TME has led to a
reduction in LOS, with a median hospital stay of approximate-
ly 10 days [12–14]. This corresponds with the results in the
control group in our study (median hospital stay of 10 days).
In our study, nearly all patients (98%) that underwent a LAR
with an anastomosis received a temporary diverting stoma.
Recently, a randomised multicenter trial, a multicenter analysis
and meta-analysis have been published on this subject, report-
ing a significant decline in symptomatic anastomotic leakage
after low anterior resections when a diverting stoma was per-
formed [15–18]. However, many recent studies on laparoscopic
low anterior resections showed a temporary diversion rate as
low as 19–26%, suggesting this assumption is not widely
accepted [11, 19, 20]. The symptomatic anastomotic leakage
rate among all low anterior resections performed in our study
was 17.3%, which is relatively high compared to other studies
including patients with a diverting stoma (7.8% in amulticenter
analysis) [16]. This could partly be due to the preoperative
treatment. Seven of these nine patients received short scheme
RT followed by a LAR. The other two patients received a long
scheme RT. Preoperative RT has been associated with higher
anastomotic leakage rates, compared with no preoperative
treatment [21–23]. Furthermore, in our study LAR was also
performed in cases with very low tumours located at 2–4 cm
from the anal verge. Low anastomoses have also been associ-
ated with higher rates of anastomotic leakages [22, 23].
In addition, a stoma requires extra postoperative care and
can be a source of postoperative complications. Furthermore,
patients could only be discharged when stoma care was suffi-
cient. Therefore, the presence of a stoma could be a factor
delaying early discharge. There was no difference in diversion
rate between ERAS and control groups. Nevertheless, the
overall hospital stay might have been shorter and better com-
parable with other study results if a diverting stoma was not
routinely performed.
Both groups were comparable for demographics and
patient-related factors, except for the presence of diabetes,
which was more likely to occur in the ERAS group (N09)
compared to the control group (N01). This will not bias our
results in favour of our hypothesis because diabetes has
been associated with delayed wound healing and impaired
anastomotic strength. These factors are more likely to com-
plicate and delay recovery than accelerate it [24, 25]. Addi-
tionally, the multivariate regression analysis supported this
assumption. As mentioned earlier, the preoperative therapy
with chemo radiation was only used in the ERAS group.
Long scheme RT was more frequent within the control
group. Patients treated with chemo radiation preoperatively
are more prone to develop postoperative complications such
as wound healing problems and anastomotic dehiscence,
due to elevated metalloproteinase activity [26, 27]. The
higher incidence of chemo radiation in the ERAS group
would therefore be more of a disadvantage than an advan-
tage with respect to postoperative recovery and length of
hospital stay, possibly even underestimating the results pre-
sented in this study. On the other hand, no higher anasto-
motic leakage rate was found in the chemo radiation group.
Another possible confounder of the study could be the
learning curve for a surgeon to become an expert in laparo-
scopic colorectal surgery. The laparoscopic technique for
TME was introduced in our institution in 2003. In order to
rule out factors that could be associated with the learning
curve of the surgeons, we excluded all patients who received
a laparoscopic rectal resection in the first year after the
introduction of this technique. However, the learning curve
for laparoscopic left sided colorectal resections is long (up
to 62 cases) [28]. The surgeons in our institution had done
approximately 25–30 cases per surgeon in the first year. The
mean operating time, a factor that is negatively correlated
with the learning curve, tended to be longer in the control
group, but this difference did not reach statistical signifi-
cance (p00.068). The conversion rate, also associated with a
learning curve, was 6.5% in the ERAS group and 13.2% in
the control group (p00.30). Although both variables that
indicated the presence of a learning curve did not differ
significantly between the ERAS and control groups, we
cannot safely exclude these factors as possible confounders
in our results, based on our relatively small study sample.
After reviewing factors that could possibly delay discharge,
we found a trend towards more urological complications in
the ERAS group. Many patients required a urinary catheter
longer than 2 days postoperatively (according to the protocol),
mostly because of persistent urinary bladder retention. Twelve
patients within this group even left the hospital with their
urinary catheter still in place. We could not find a reasonable
explanation for the difference between both groups regarding
the urological complications. There could be a correlation
with the preoperative treatment (chemo radiation), possibly
leading to more nerve damage, but there are no studies con-
firming this hypothesis. Another explanation could be a better
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registration of urological complications in the ERAS group by
the nursing and medical staff, leading to possible bias.
Recommendations
Although this study shows a significant reduction in hospital
stay after the introduction of the ERAS protocol in laparoscopic
TME for rectal cancer, no definitive conclusions can be drawn.
The results suggest this decline in postoperative hospital stay is
directly related to the ERAS protocol. However, based on our
study design, we cannot confirm ERAS to be the causal factor.
In the future, a randomised controlled clinical trial is
required to validate the results we presented here.
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